FENC Fennec Pharmaceuticals Inc. Stock Quote

FENC [NASD]

Index	-	P/E	-	EPS (ttm)	-0.63	Insider Own	0.10%	Shs Outstand	26.02M	Perf Week	5.07%
Market Cap	150.97M	Forward P/E	156.76	EPS next Y	0.04	Insider Trans	0.00%	Shs Float	21.61M	Perf Month	-3.01%
Income	-16.30M	PEG	-	EPS next Q	-0.12	Inst Own	44.00%	Short Float	1.23%	Perf Quarter	19.10%
Sales	-	P/S	-	EPS this Y	12.70%	Inst Trans	0.79%	Short Ratio	7.41	Perf Half Y	-41.12%
Book/sh	0.48	P/B	12.08	EPS next Y	100.00%	ROA	-68.20%	Target Price	11.20	Perf Year	-14.45%
Cash/sh	0.70	P/C	8.25	EPS next 5Y	-	ROE	-93.70%	52W Range	3.82 - 10.08	Perf YTD	31.82%
Dividend	-	P/FCF	-	EPS past 5Y	-25.00%	ROI	-	52W High	-44.24%	Beta	-0.06
Dividend %	-	Quick Ratio	9.00	Sales past 5Y	-	Gross Margin	-	52W Low	47.05%	ATR	0.37
Employees	10	Current Ratio	9.00	Sales Q/Q	-	Oper. Margin	-	RSI (14)	45.87	Volatility	5.19% 7.12%
Optionable	Yes	Debt/Eq	0.40	EPS Q/Q	22.00%	Profit Margin	-	Rel Volume	0.86	Prev Close	5.80
Shortable	Yes	LT Debt/Eq	0.36	Earnings	May 12 BMO	Payout	-	Avg Volume	35.81K	Price	5.62
Recom	2.00	SMA20	-3.41%	SMA50	-3.98%	SMA200	-14.15%	Volume	10,071	Change	-3.10%

Jun-05-20

Initiated

Cantor Fitzgerald

Overweight

$18

Oct-11-18

Initiated

Goldman

Buy

May-23-22 07:29AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire
May-12-22 06:00AM	Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business Update GlobeNewswire
May-06-22 05:17PM	Inflation crushes market caps of Triangle's biggest public companies except these ones American City Business Journals
May-03-22 09:55AM	Can Adherex Technologies Inc. (FENC) Climb 92% to Reach the Level Wall Street Analysts Expect? Zacks
Apr-27-22 06:00AM	Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK GlobeNewswire -9.27%
Mar-25-22 07:00AM	Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference GlobeNewswire
Mar-24-22 06:00AM	Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for Pedmark GlobeNewswire -6.41%
Feb-28-22 06:00AM	Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update GlobeNewswire
Jan-31-22 06:00AM	Fennec Pharmaceuticals Announces Management Change GlobeNewswire +5.20%
Jan-27-22 05:38PM	Hartford Financial Management Inc. Buys Exelon Corp, American Electric Power Co Inc, Pinnacle ... GuruFocus.com -7.54%
Dec-14-21 07:50PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC ACCESSWIRE
Dec-13-21 10:08AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC PR Newswire
Dec-01-21 07:06AM	RTP drugmaker suffers another regulatory setback American City Business Journals -11.39%
Nov-30-21 04:20PM	Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down Zacks -8.16%
10:57AM	FENC Fennec Pharmaceuticals Inc. Investors Who Have Lost More Than $25,000 Are Encouraged To Contact Kehoe Law Firm, P.C. Securities Class Action Investigation GlobeNewswire
06:00AM	Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors GlobeNewswire
05:49AM	When Will Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Breakeven? Simply Wall St.
Nov-29-21 07:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fennec Pharmaceuticals Inc. - FENC GlobeNewswire -50.41%
07:24AM	Fennec Pharmaceuticals Expects FDA Rejection for New Drug Investing.com
06:00AM	Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors GlobeNewswire
Nov-10-21 06:00AM	Fennec Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Oct-05-21 08:30AM	4 Breakout Stocks for Impressive Returns Zacks
Sep-29-21 02:27PM	Hedge Funds Are Piling Into Fennec Pharmaceuticals Inc. (FENC) Insider Monkey
Sep-09-21 06:00AM	Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-10-21 06:00AM	Fennec Pharmaceuticals Announces Second Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Aug-02-21 03:18AM	Is Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Popular Amongst Institutions? Simply Wall St.
Jun-29-21 05:30PM	Fennec Announces Results of Annual Meeting GlobeNewswire
Jun-24-21 06:00AM	Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility GlobeNewswire +7.52%
Jun-22-21 07:17AM	Fennec Pharma Stock Is Trading Higher As Pedmark Is Under FDA Review For Chemo-Induced Toxicity Benzinga +5.13%
06:00AM	Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for PEDMARK GlobeNewswire
Jun-03-21 03:33AM	Here's Why We're Not Too Worried About Fennec Pharmaceuticals' (NASDAQ:FENC) Cash Burn Situation Simply Wall St.
May-28-21 06:00AM	Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for PEDMARK GlobeNewswire +6.66%
May-13-21 06:00AM	Fennec Pharmaceuticals Announces First Quarter 2021 Financial Results and Provides Business Update GlobeNewswire
Apr-04-21 05:54AM	Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Simply Wall St.
Mar-30-21 06:00AM	Fennec Announces Fiscal Year 2020 Financial Results and Provides Business Update GlobeNewswire
Feb-03-21 01:59AM	What Type Of Shareholders Make Up Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) Share Registry? Simply Wall St.
Dec-09-20 07:51AM	New Strong Sell Stocks for December 9th Zacks -5.74%
Dec-02-20 11:27PM	Here is What Hedge Funds Think About Fennec Pharmaceuticals Inc. (FENC) Insider Monkey
Nov-27-20 10:27AM	New Strong Sell Stocks for November 27th Zacks
Nov-19-20 10:02AM	New Strong Sell Stocks for November 19th Zacks
Nov-16-20 07:02AM	Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-05-20 07:46AM	Here's Why We're Not Too Worried About Fennec Pharmaceuticals' (NASDAQ:FENC) Cash Burn Situation Simply Wall St.
Nov-02-20 03:57PM	FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 2, 2020 in the Class Action Filed on Behalf of Fennec Pharmaceuticals Inc. Limited Shareholders Newsfile
02:30PM	FENC Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020 ACCESSWIRE
01:10PM	LAWSUITS FILED AGAINST POR, FENC and CLNC - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:29AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 2, 2020 - FENC Newsfile
10:00AM	FENC Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020 Newsfile
09:15AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of POR, FENC and NKLA ACCESSWIRE
09:00AM	FENC DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Contact Firm Before End of Important Deadline Today in Securities Class Action FENC ACCESSWIRE
08:00AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
06:30AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of POR, FENC and NNOX ACCESSWIRE
12:15AM	NOVEMBER 2 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Nov-01-20 03:46PM	FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action FENC GlobeNewswire
Oct-30-20 09:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm GlobeNewswire
08:05PM	LAWSUITS FILED AGAINST FENC, BMRN and CACC - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
06:45PM	FENC Final Deadline Alert: Rosen, Top Ranked Global Counsel, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - FENC Newsfile
02:45PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FENC, TCMD and TRQ ACCESSWIRE
12:00PM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC) Business Wire
11:40AM	FINAL DEADLINE NOVEMBER 2: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:01AM	FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 2, 2020 in the Class Action Filed on Behalf of Fennec Pharmaceuticals Inc. Limited Shareholders Newsfile
11:00AM	FENC Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fennec Pharmaceuticals Inc. Investors of Class Action and Lead Plaintiff Deadline: November 2, 2020 Business Wire
09:35AM	DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Oct-29-20 09:22PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 2, 2020 - FENC Newsfile
07:55PM	FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:00PM	CLASS ACTION UPDATE for FENC, LX and CLNC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:30AM	FENC CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files a Securities Fraud Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC) PR Newswire
11:12AM	FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc. ACCESSWIRE
11:00AM	UPLCQ, FENC & HDB Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions ACCESSWIRE
10:40AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FENC, FLDM and GTX ACCESSWIRE
09:38AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Oct-28-20 09:39PM	FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 2, 2020 in the Class Action Filed on Behalf of Fennec Pharmaceuticals Inc. Limited Shareholders Newsfile -8.32%
08:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Business Wire
07:15PM	FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action - FENC PR Newswire
02:27PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 2, 2020 - FENC Newsfile
01:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FENC, LVS and FAF ACCESSWIRE
01:00PM	FINAL DEADLINE NOVEMBER 2: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:30PM	Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC) PR Newswire
11:45AM	LAWSUITS FILED AGAINST FENC, COTY and BMRN - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
11:00AM	UPLCQ, FENC & HDB Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions ACCESSWIRE
10:20AM	CLASS ACTION UPDATE for PT, FENC and NKLA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:57AM	MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Oct-27-20 12:00PM	UPLCQ, FENC & HDB Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions GlobeNewswire +9.67%
11:10AM	FINAL DEADLINE THIS MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:00AM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC) PR Newswire
10:00AM	CLASS ACTION UPDATE for UPLCQ, FENC and COTY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:57AM	FENC SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc. ACCESSWIRE
09:26AM	MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Oct-26-20 05:24PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 2, 2020 - FENC Newsfile
03:50PM	FINAL DEADLINE NEXT WEEK: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:55PM	Lawsuits Filed Against POR, FENC and BTU - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
12:30PM	DEADLINE ALERT for FENC, POR, GTX, GTXMQ, BMRN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:45AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of FENC, COTY and BTU ACCESSWIRE
11:00AM	UPLCQ, FENC & HDB Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions ACCESSWIRE
11:00AM	DEADLINE ALERT for FENC, POR, HDB, and UPLCQ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:26AM	FENC INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors That Only 7 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fennec Pharmaceuticals Inc. PR Newswire
Oct-23-20 07:10PM	Lawsuits Filed Against PROG, FENC and CACC - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
06:30PM	ROSEN, A LEADING LAW FIRM, Reminds Fennec Pharmaceuticals Inc. Investors of the Important November 2 Deadline in Securities Class Action - FENC Newsfile
04:55PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FENC, BMRN and CACC ACCESSWIRE
04:10PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fennec Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:40AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VXRT, FENC and NKLA ACCESSWIRE

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate that has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
RALLIS CHRIS A	Director	Mar 08	Option Exercise	0.57	17,592	10,000	20,925	Mar 08 08:24 AM
RALLIS CHRIS A	Director	Oct 21	Option Exercise	1.50	3,333	5,000	3,333	Oct 21 03:40 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience